Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer

Clinical trial NCT01199393 · COMPLETED

Trial details

NCT number: NCT01199393
Sponsor: Peking University Cancer Hospital & Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Neoplasm Drug Therapy Polymorphism,Single Nucleotide

Start date: 2010-08-01
Primary completion: 2014-12-01
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.